
NAFDAC Launches New App So Nigerians Can Report Fake Drugs From Their Phones
NAFDAC has upgraded the Med Safety App and it now lets anyone in Nigeria report a suspicious drug, fake product, or bad reaction directly from their phone. Here is what it does and how to use it.
NAFDAC has launched an improved version of the Med Safety App. It is free, works on Android and iOS, and any Nigerian can use it today.
The app lets you report two things directly to NAFDAC from your phone:
Fake or substandard medicines. If a drug looks wrong, such as an altered expiry date, suspicious packaging, or a missing NAFDAC number, or if it simply did not work, you can report it. You can also upload photos to support your report.
Adverse drug reactions. If you or someone you know experienced an unexpected side effect after taking a medicine, that can be reported too.
Every report goes straight to NAFDAC for investigation.
Why This Matters
Fake drugs do not just waste money. They cause treatment failure, serious illness, and death.
Substandard antimalarials and antibiotics are especially dangerous because patients trust them and go untreated without knowing why.
NAFDAC cannot monitor every market in Nigeria alone. The Med Safety App turns every Nigerian into a frontline reporter.
When you report a suspicious product, NAFDAC can investigate, issue a public alert, and pull it off the shelves before more people are harmed.
How to Get It
Search "NAFDAC Med Safety" on the Google Play Store or Apple App Store. A web version is also available for desktop users.
Pharmacists, medicine vendors, community health workers, patients, and carers are all encouraged to download it.
Verify First. Then Report.
Before you report a product, check if it is registered at all.
Search the NAFDAC number or product name on VerifyProduct.ng — it takes five seconds, and it is completely free.
If the product fails verification, report it on the MedSafety app.
That combination — verify, then report — is how you protect yourself and everyone else who might buy the same product.
Share this alert